A nomogram was constructed to provide an individualized risk assessment for HER2-positive breast cancer classification by integrating the selected deep learning-based features from the MRI sequences (T1-weighted, T2-weighted, and DCE) and clinically relevant features (Figure 12). The gene discussed is ERBB2; the disease is breast carcinoma.